Additional Health and Economic Impact of the Bivalent Versus the Quadrivalent HPV Vaccine in Taiwan: Results of a Prevalence-based Model
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1
- 主要终点
- Annual number of lesions prevented by each vaccine
研究概览
简要总结
This study compares the health and economic impact of the bivalent HPV vaccine (HPV-1) and the quadrivalent HPV vaccine (HPV-2).
详细描述
This study uses a prevalence-based model (by using efficacy data from each vaccine's respective trials and published cost data for Taiwan) which estimates the differences in lesions, genital warts, cervical cancer and costs from a healthcare payer's perspective prevented between HPV-1 and HPV-2 vaccines during one year (when all women are vaccinated). It also analyses costs from a societal perspective.
研究设计
- 研究类型
- Observational
入排标准
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Female subjects vaccinated with either HPV-1 or HPV-2 vaccines in Taiwan (hypothetical group).
排除标准
- •Not applicable.
结局指标
主要结局
Annual number of lesions prevented by each vaccine
时间窗: Over a one-year period
Lesion related total cost averted by each vaccine
时间窗: Over a one-year period
Additional costs averted by HPV-1 vaccine compared to HPV-2 vaccine
时间窗: Over a one-year period
次要结局
未报告次要终点